Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 9, 2018, Pages 714-724

  Eckel, Nathalie ^a,b,c   Li, Yanping ^d   Kuxhaus, Olga ^a   Stefan, Norbert ^b,e,f   Hu, Frank B ^d,g   Schulze, Matthias B ^a,b,c  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY OF POTSDAM   (Germany)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLICALLY HEALTHY OBESE; METABOLICALLY UNHEALTHY OBESE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; AGED; COMPLICATION; DIABETIC COMPLICATION; METABOLIC SYNDROME X; METABOLICALLY BENIGN OBESITY; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; METABOLIC SYNDROME; MIDDLE AGED; OBESITY; OBESITY, METABOLICALLY BENIGN; PHENOTYPE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 85047633458     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(18)30137-2     Document Type: Article

References (30)

1. Kivimaki, M, Kuosma, E, Ferrie, JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health 2 (2017), e277–e285.
2. Yusuf, S, Hawken, S, Ounpuu, S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952.
3. Stefan, N, Haring, HU, Hu, FB, Schulze, MB, Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1 (2013), 152–162.
4. Stefan, N, Haring, HU, Schulze, MB, Metabolically healthy obesity: the low-hanging fruit in obesity treatment?. Lancet Diabetes Endocrinol 6 (2018), 249–258.
5. Eckel, N, Meidtner, K, Kalle-Uhlmann, T, Stefan, N, Schulze, MB, Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol 23 (2016), 956–966.
6. Kramer, CK, Zinman, B, Retnakaran, R, Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 159 (2013), 758–769.
7. Lassale, C, Tzoulaki, I, Moons, KGM, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J 39 (2017), 397–406.
8. Caleyachetty, R, Thomas, GN, Toulis, KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol 70 (2017), 1429–1437.
9. Appleton, SL, Seaborn, CJ, Visvanathan, R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 36 (2013), 2388–2394.
10. Soriguer, F, Gutierrez-Repiso, C, Rubio-Martin, E, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 98 (2013), 2318–2325.
11. Kim, NH, Seo, JA, Cho, H, et al. Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: The Korean Genome and Epidemiology Study. Medicine (Baltimore), 95, 2016, e3384.
12. Lee, SH, Yang, HK, Ha, HS, et al. Changes in metabolic health status over time and risk of developing type 2 diabetes: A prospective cohort study. Medicine (Baltimore), 94, 2015, e1705.
13. Achilike, I, Hazuda, HP, Fowler, SP, Aung, K, Lorenzo, C, Predicting the development of the metabolically healthy obese phenotype. Int J Obes (Lond) 39 (2015), 228–234.
14. Hamer, M, Bell, JA, Sabia, S, Batty, GD, Kivimaki, M, Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur J Endocrinol 173 (2015), 703–708.
15. Bell, JA, Hamer, M, Sabia, S, Singh-Manoux, A, Batty, GD, Kivimaki, M, The natural course of healthy obesity over 20 years. J Am Coll Cardiol 65 (2015), 101–102.
16. Kabat, GC, Wu, WY, Bea, JW, et al. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. Int J Obes (Lond) 41 (2017), 170–177.
17. Lavie, CJ, De Schutter, A, Milani, RV, Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol 11 (2015), 55–62.
18. Colditz, GA, Manson, JE, Hankinson, SE, The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 6 (1997), 49–62.
19. Rimm, EB, Stampfer, MJ, Colditz, GA, Chute, CG, Litin, LB, Willett, WC, Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1 (1990), 466–473.
20. Colditz, GA, Martin, P, Stampfer, MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123 (1986), 894–900.
21. Manson, JE, Rimm, EB, Stampfer, MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338 (1991), 774–778.
22. Rose, GA, Blackburn, H, Gillium, RF, Prineas, RJ, Cardiovascular survey methods. Monograph Series No. 56, 2nd ed, 1982, World Health Organization.
23. Rich-Edwards, JW, Corsano, KA, Stampfer, MJ, Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 140 (1994), 1016–1019.
24. McCullough, ML, Feskanich, D, Stampfer, MJ, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76 (2002), 1261–1271.
25. Phillips, CM, Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci 1391 (2017), 85–100.
26. Park, YW, Zhu, S, Palaniappan, L, Heshka, S, Carnethon, MR, Heymsfield, SB, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163 (2003), 427–436.
27. Mongraw-Chaffin, M, Foster, MC, Kalyani, RR, et al. Obesity severity and duration are associated with incident metabolic syndrome: Evidence against metabolically healthy obesity from the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab 101 (2016), 4117–4124.
28. Hu, FB, Stampfer, MJ, Haffner, SM, Solomon, CG, Willett, WC, Manson, JE, Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25 (2002), 1129–1134.
29. Emerging Risk Factors Collaboration, Sarwar, N, Gao, P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
30. Grundy, SM, Cleeman, JI, Daniels, SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005), 2735–2752.